Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at ...
Brandon Dawson, co-founder of 10X Health System and Cardone Ventures, outlines how genetics, biomarkers, and AI are reshaping modern wellness, as the company pushes a data-driven model of personalised ...
Organoid screening platforms are transforming drug discovery by providing physiologically relevant 3D models that improve ...
Thryv Therapeutics Inc., a clinical-stage biotechnology company advancing novel serum glucocorticoid inducible kinase 1 (SGK1) inhibitors for inherited cardiac arrhythmias, cardiometabolic diseases, ...
Stacker compiled a collection of 70 images that show how the '70s changed the world. See photos of the decade's defining ...
Big Tech such as Google and Facebook-parent Meta are moving fast to reduce dependence on external chip suppliers by expanding their custom chip efforts ...
Pharmaceutical Technology on MSN
The innovators working to make in vivo cell therapy a reality
As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial ...
Albert Maguire '82 and Emeritus Professor David Gross won marquee Breakthrough Prizes for outstanding scientific discovery, ...
Hyderabad: Researchers at the CSIR-Centre for Cellular and Molecular Biology (CSIR-CCMB) have found that cyanobacterial ...
Seven Princeton faculty members and two visiting artists have received 2026 Guggenheim Fellowships supporting scholars in the ...
A remarkable genetic breakthrough has uncovered what may be one of the clearest snapshots yet of a Neanderthal “community” ...
Drug Farm today announced that preliminary immunologic and clinical results from its Phase 1b study of DF-003, a first-in-class oral ALPK1 inhibitor, will be presented in a podium session at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results